Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection

Pediatric Infectious Disease Journal

Volumn 15, Issue 3, 1996, Pages 223-231

  Vajro, Pietro ^a   Tedesco, Mariangela ^a   Fontanella, Angiola ^a   De Vincenzo, Anna ^a   Vecchione, Raffaella ^a   Ammendola, Rosario ^a   Terracciano, Luigi Maria ^a,b   Novissimo, Antonio ^a   Vegnente, Angela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

children; chronic hepatitis B; Interferon treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; PARACETAMOL; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; INFLUENZA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS REPLICATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; LIVER; MALE; PREDICTIVE VALUE OF TESTS; PREDNISONE; PROSPECTIVE STUDIES; TIME FACTORS; VIRUS REPLICATION;

EID: 0030009672     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199603000-00010     Document Type: Article

References (43)

1. Bortolotti F, Calzia R, Cadrobbi P, et al. Liver cirrhosis associated with chronic hepatitis B infection in childhood. J Pediatr 1986;108:224-7.
2. Vajro P, Hadchouel P, Hadchouel M, Bernard O, Alagille D. Incidence of cirrhosis in children with chronic hepatitis. J Pediatr 1990;117:392-6.
3. Wu TC, Tong MJ, Hwang B, Lee SD, Hu MM. Primary hepatocellular carcinoma and hepatitis B infection during childhood. Hepatology 1987;7:46-8.
4. Bortolotti F, Di Marco V, Vajro P, et al. Long-term evolution of chronic delta hepatitis in children. J Pediatr 1993;122: 736-8.
5. Vajro P, Orso G, Pignata C, Greco L, Rizzetto M. HBsAg positive chronic active hepatitis (CAH) and delta infection in children [Abstract]. Pediatr Res 1983;17:434.
6. Immunization Practices Advisory Committee (ACIP), Center for Diseases Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991;40: 1-25.
7. Stevens CE, Toy PT, Taylor PE, Lee T, Yip HY. Prospects for control of hepatitis B virus infection: implication of childhood vaccination and long-term protection. Pediatrics 1992;90: 170-3.
8. Di Bisceglie AM. Interferon therapy for chronic viral hepatitis [Editorial]. N Engl J Med 1994;330:137-8.
9. Perrillo R. Interferon in the management of chronic hepatitis B. Dig Dis Sci 1993;38:577-93.
10. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with Hepatitis B e antigen-positive chronic hepatitis B. Ann Internal Med 1993;119:312-23.
11. Dusheiko G, Hoofnagle JH. Hepatitis B. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. vol 1. Oxford, U.K.: Oxford University Press, 1991:571-92.
12. Lai CL, Lok ASF, Lin HJ, Wu PC, Yeoh EK, Yeung CY. Placebo- controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987;2:877-80.
13. Lai CL, Lin HJ, Lau JYN, et al. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 1991;78:155-63.
14. Sokal EM, Wirth S, Goyens P, Depreterre A, Cornu C. Interferon alfa-2b therapy in children with chronic hepatitis B. Gut 1993;Suppl.:S87-90.
15. Ruiz-Moreno M, Rua MJ, Molina J, et al. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology 1991;13:1035-9.
16. Ruiz-Moreno M, Jimenez J, Porres JC, Bartolome J, Moreno A, Carreno A. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B. Digestion 1990;45:26-33.
17. Utili R, Sagnelli E, Galanti B, et al. Prolonged treatment of children with chronic hepatitis B with recombinant a2a-interferon: a controlled, randomized study. Am J Gastroenterol 1991;86:327-31.
18. Barbera C, Bortolotti F, Crivellaro C, et al. Recombinant Interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 1994;20: 287-90.
19. Perrillo R, Regenstein F, Peters M, et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis: a randomized controlled trial. Ann Internal Med 1988;109:95-9.
20. Perrillo RP, Schiff ER, Davis GL, et al. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of the chronic hepatitis B. N Engl J Med 1990;323:295-301.
21. Hoofnagle JH. Interferon therapy of viral hepatitis. In: Baron S, Coppenhaver DH, Dianzania F, et al., eds. Interferon: principles and medical applications. Galveston, TX: University of Texas Medical Branch, 1991:433-62.
22. Krogsgaard K. Does corticosteroid pretreatment enhance the effect of alfa interferon treatment in chronic hepatitis B? J Hepatol 1994;20:159-62.
23. Utili R, Sagnelli E, Gaeta GB, et al. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study. J Hepatol 1994; 20:163-7.
24. Spiegel RJ. Intron A (interferon alfa-2b): clinical overview and future directions. Semin Oncol 1986;13 (Suppl. 2): 89-101.
25. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
26. Bianchi L, Gudat F. Immunopathology of hepatitis B. In: Progress in liver disease. Popper H, Schaffner F, eds. New York: Grune and Stratton, 1979:371-92.
27. Baginski I, Ferrie A, Watson R, Mack D. Detection of hepatitis B virus. In: Innis MA, Gelfand DH, Snisky J, et al., eds. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, 1990:348-55.
28. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Changes in hepatitis B e antigen/antibody system in children with chronic hepatitis B virus infection. J Pediatr 1983;103: 718-22.
29. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990;99:805-10.
30. Bruguera M, Amat L, Garcia O, et al. Treatment of chronic hepatitis B in children with recombinant alfa interferon. J Clin Gastroenterol 1983;17:296-9.
31. Zancan L, Chiaromonte M, Ferrarese N, Zacchello F. Pediatric HBsAg chronic liver disease and adult asymptomatic carrier status: two stages of the same entity. J Pediatr Gastroenterol Nutr 1990;11:380-4.
32. Karayiannis P, Kanatakis S, Thomas HC. Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment. J Hepatol 1990;10:350-2.
33. Korenman J, Baker B, Waggoner J, et al. Long-term remission in chronic hepatitis B after alpha-interferon therapy. Ann Internal Med 1991;114:629-34.
34. Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992;15:382-6.
35. Carreno V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of hepatitis B chronic carriers who respond to interferon therapy. J Hepatol 1992;15:102-6.
36. Loriot MA, Marcellin P, Bismuth E, et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs serocon-version in patients with chronic hepatitis B. Hepatology 1992;15:32-6.
37. Wirth S, Bahn, Pohlenz, Bortolotti F. HBV DNA can be detectable in children with chronic hepatitis B after clearance of HBsAg [Abstract]. J Pediatr Gastroenterol Nutr 1994;19:365.
38. Perrillo RP, Mason AL. Therapy for hepatitis B virus infection. Gastroenterol Clin North Am 1994;23:581-601.
39. Brook MG, Petrovic L, McDonald JA, Scheuer PJ, Thomas HC. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection. J Hepatol 1989;8:218-25.
40. Vajro P, Orso G, D'Antonio A, et al. Inefficacy of immunosuppressive treatment in HBsAg positive, delta negative, moderate chronic active hepatitis in children. J Pediatr Gastroenterol Nutr 1985;4:26-31.
41. Pignata C, Vajro P, Vegnente A, et al. Effect of prednisone on DR-positive T-cells in children with chronic active hepatitis B. J Pediatr Gastroenterol Nutr 1989;8:288-91.
42. Hu KQ, Vierling JM. Molecular diagnostic techniques for viral hepatitis. Gastroenterol Clin North Am 1994;23: 479-98.
43. Vajro P, Tedesco M, Fontanella A, et al. Treatment of chronic B hepatitis in children: results of a controlled trial with prolonged and high-dose alpha 2b recombinant (R) interferon ± prednisone (PDN) treatment.. J Pediatr Gastroenterol Nutr 1993;17:465.